10-Q Filing

Oruka Therapeutics, Inc. CIK: 907654 Q1 2015

Filing Information

Form Type	10-Q
Accession Number	`0001564590-15-004080`
Period End Date	20150331
Filing Date	20150512
Fiscal Year	2015
Fiscal Period	Q1
XBRL Instance	abio-20150331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 47 Income Statement 19 Cash Flow Statement 41 Stockholders Equity 14

Balance Sheet 47 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.35M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$21.20M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.18M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	21.15M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	21.20M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$16.76M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	21.15M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$490.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$134.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	21.20M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$12.67M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$15.49M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$36.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$34.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$608.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$553.00K	USD	Point-in-time
Total assets	`Assets`	$13.26M	USD	Point-in-time
Total assets	`Assets`	$16.13M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$651.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$795.00K	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$329.00K	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$123.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherLiabilitiesCurrent`	$264.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherLiabilitiesCurrent`	$359.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.13M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.39M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$3.00K	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.13M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.39M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized at March 31, 2015 and December 31, 2014; 21,198,411 and 21,150,486 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively	`CommonStockValue`	$21.00K	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized at March 31, 2015 and December 31, 2014; 21,198,411 and 21,150,486 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively	`CommonStockValue`	$21.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$99.47M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$99.34M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-87.37M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-84.62M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$15.58M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$12.13M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$14.74M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$13.26M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$16.13M	USD	Point-in-time

Income Statement 19 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$1.31M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.71M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.08M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.04M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$2.74M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$2.39M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.39M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.74M	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$1.00K	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$2.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.00K	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-2.39M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-9.69M	USD	Annual
Net loss and comprehensive loss	`NetIncomeLoss`	$-2.74M	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.13	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.13	USD	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	21.17M	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	18.79M	shares	1 Quarter

Cash Flow Statement 41 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.39M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.69M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.74M	USD	1 Quarter
Depreciation	`DepreciationAndAmortization`	$4.00K	USD	1 Quarter
Depreciation	`DepreciationAndAmortization`	$3.00K	USD	1 Quarter
Amortization of deferred charges	`AmortizationOfDeferredCharges`	$31.00K	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$158.00K	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$130.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$251.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$139.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$698.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-45.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-144.00K	USD	1 Quarter
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-348.00K	USD	1 Quarter
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-206.00K	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-43.00K	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-117.00K	USD	1 Quarter
Other	`IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet`	$2.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.69M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.11M	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-2.00K	USD	1 Quarter
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$9.02M	USD	1 Quarter
Repayment of principal on vendor finance agreement	`RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths`	$51.00K	USD	1 Quarter
Repayment of principal on vendor finance agreement	`RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths`	$55.00K	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$8.13M	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-55.00K	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-3.17M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$4.45M	USD	1 Quarter
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$15.35M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$21.20M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$12.18M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$16.76M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$15.35M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$21.20M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$12.18M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$16.76M	USD	Point-in-time
Interest paid	`InterestPaid`	$1.00K	USD	1 Quarter
Interest paid	`InterestPaid`	$1.00K	USD	1 Quarter
Vendor finance agreement	`VendorFinanceAgreement`	$138.00K	USD	1 Quarter
Vendor finance agreement	`VendorFinanceAgreement`	$128.00K	USD	1 Quarter

Stockholders Equity 14 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$15.58M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$12.13M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$14.74M	USD	Point-in-time
Issuance of common stock for cash, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$7.87M	USD	Annual
Issuance of common stock upon exercise of warrants for cash, value	`IssuanceOfCommonStockUponExerciseOfWarrantsForCashValue`	$338.00K	USD	Annual
Issuance of common stock upon vesting of Restricted Stock Units, value	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$-2.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$130.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$647.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-2.39M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.69M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.74M	USD	1 Quarter
Ending Balance	`StockholdersEquity`	$15.58M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$12.13M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$14.74M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.